ES2128638T3 - Preparacion de absorcion percutanea. - Google Patents

Preparacion de absorcion percutanea.

Info

Publication number
ES2128638T3
ES2128638T3 ES95117714T ES95117714T ES2128638T3 ES 2128638 T3 ES2128638 T3 ES 2128638T3 ES 95117714 T ES95117714 T ES 95117714T ES 95117714 T ES95117714 T ES 95117714T ES 2128638 T3 ES2128638 T3 ES 2128638T3
Authority
ES
Spain
Prior art keywords
percutaneous absorption
preparation
carbon atoms
pressure sensitive
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95117714T
Other languages
English (en)
Spanish (es)
Inventor
Hitoshi Akemi
Takateru Muraoka
Kazuhiro Higashio
Yutaka Suzuki
Saburo Otsuka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Original Assignee
Nitto Denko Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp filed Critical Nitto Denko Corp
Application granted granted Critical
Publication of ES2128638T3 publication Critical patent/ES2128638T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
ES95117714T 1994-11-15 1995-11-09 Preparacion de absorcion percutanea. Expired - Lifetime ES2128638T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28034294A JP3576608B2 (ja) 1994-11-15 1994-11-15 貼付剤および貼付製剤

Publications (1)

Publication Number Publication Date
ES2128638T3 true ES2128638T3 (es) 1999-05-16

Family

ID=17623676

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95117714T Expired - Lifetime ES2128638T3 (es) 1994-11-15 1995-11-09 Preparacion de absorcion percutanea.

Country Status (6)

Country Link
US (1) US5650165A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0711551B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3576608B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2162208C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69508342T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2128638T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0827003A (ja) * 1994-07-22 1996-01-30 Sekisui Chem Co Ltd 経皮吸収製剤
ES2196208T3 (es) * 1996-03-09 2003-12-16 Nitto Denko Corp Preparacion percutanea adhesiva.
ES2239372T3 (es) 1997-07-17 2005-09-16 Nitto Denko Corporation Lamina adhesiva medica y su produccion.
WO1999032153A1 (en) 1997-12-22 1999-07-01 Alza Corporation Monoglyceride and ethyl palmitate permeation enhancer compositions
US6160165A (en) 1998-12-10 2000-12-12 Aesgen, Inc. Method for preparation of disodium pamidronate
US6794536B1 (en) 1998-12-10 2004-09-21 Aesqen, Inc. Method for preparation of disodium pamidronate
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
CA2347330C (en) * 2001-05-10 2002-03-12 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
KR100458148B1 (ko) * 2001-10-29 2004-11-26 포라 가세이 고교 가부시키가이샤 피부 분석 시스템
JP4323138B2 (ja) * 2002-06-05 2009-09-02 日東電工株式会社 経皮吸収型製剤およびその製造方法
US20040137039A1 (en) * 2002-07-22 2004-07-15 Trustees Of Stevens Institute Of Technology Methods for controlled release of molecules from layered polymer films
US20050008828A1 (en) * 2002-07-25 2005-01-13 Trustees Of Stevens Institute Of Technology Patterned polymer microgel and method of forming same
US20060014003A1 (en) * 2003-07-24 2006-01-19 Libera Matthew R Functional nano-scale gels
CA2541974A1 (en) * 2003-10-02 2005-04-14 Trustees Of Stevens Institute Of Technology Capsules of multilayered neutral polymer films associated by hydrogen bonding
US7105263B2 (en) * 2003-12-30 2006-09-12 Samsung Electronics Company Dry toner comprising encapsulated pigment, methods and uses
US20060008432A1 (en) * 2004-07-07 2006-01-12 Sebastiano Scarampi Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
JP2006288887A (ja) * 2005-04-13 2006-10-26 Nitto Denko Corp 貼付製剤
US8093039B2 (en) * 2007-04-10 2012-01-10 The Trustees Of The Stevens Institute Of Technology Surfaces differentially adhesive to eukaryotic cells and non-eukaryotic cells
NZ602274A (en) 2010-04-30 2014-05-30 Teikoku Pharma Usa Inc Propynylaminoindan transdermal compositions
JP5906302B2 (ja) 2011-03-24 2016-04-20 テイコク ファーマ ユーエスエー インコーポレーテッド 作用剤層および作用剤変換層を含む経皮組成物
US9913812B2 (en) 2011-11-09 2018-03-13 Teikoku Pharma Usa, Inc. Methods for the treatment of skin neoplasms
WO2013103514A1 (en) 2012-01-04 2013-07-11 The Trustees Of The Stevens Institute Of Technology Clay-containing thin films as carriers of absorbed molecules
KR20150059177A (ko) 2012-11-02 2015-05-29 테이코쿠 팔마 유에스에이, 인코포레이티드 프로피닐아미노인단 경피 조성물
EP4434525A4 (en) * 2021-11-15 2025-05-21 artience Co., Ltd. SELEXIPAG-CONTAINING ADHESIVE PLASTER

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
CH674618A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1987-04-02 1990-06-29 Ciba Geigy Ag
WO1989007951A1 (en) * 1988-02-26 1989-09-08 Riker Laboratories, Incorporated Transdermal estradiol delivery system
US5298258A (en) * 1989-12-28 1994-03-29 Nitto Denko Corporation Acrylic oily gel bioadhesive material and acrylic oily gel preparation
JP3273430B2 (ja) * 1989-12-28 2002-04-08 日東電工株式会社 エストロゲン含有ゲル製剤
TW218849B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1991-05-17 1994-01-11 Bristol Myers Squibb Co
CA2077369A1 (en) * 1991-09-09 1993-03-10 Hitoshi Akemi Acrylic gel material and gel-based medical preparation for percutaneous absorption employing the same
JP2819236B2 (ja) * 1994-05-06 1998-10-30 日東電工株式会社 経皮吸収製剤
JP3604177B2 (ja) 1994-09-14 2004-12-22 日東電工株式会社 経皮吸収製剤

Also Published As

Publication number Publication date
CA2162208C (en) 2006-12-19
US5650165A (en) 1997-07-22
EP0711551A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1996-05-22
JPH08143451A (ja) 1996-06-04
EP0711551A2 (en) 1996-05-15
JP3576608B2 (ja) 2004-10-13
DE69508342D1 (de) 1999-04-22
CA2162208A1 (en) 1996-05-16
DE69508342T2 (de) 1999-07-15
EP0711551B1 (en) 1999-03-17

Similar Documents

Publication Publication Date Title
ES2128638T3 (es) Preparacion de absorcion percutanea.
ES2139806T3 (es) Preparacion de absorcion percutanea que contiene dinitrato de isosorburo.
ES2152979T3 (es) Sistema terapeutico transdermal que contiene estradiol.
US3598122A (en) Bandage for administering drugs
US6767342B1 (en) Oxygen bandage system
PT81751B (pt) Processo para a preparacao de adesivos para aplicacao de medicamentos por via transdermica
DK0674913T3 (da) Ikke-okklusivt klæbende plaster til påföring af medicament i huden
AR097045A2 (es) Sistema terapéutico transdérmico
DE3881340D1 (de) Vorrichtung zur transdermalen applikation von medikamenten.
ATE173162T1 (de) Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffen
ATE238778T1 (de) Transdermales therapeutisches system zur abgabe von hormonen
KR870006906A (ko) 피부투과식 약물투여장치
ES2196055T3 (es) Dispositivo transdermico que contiene polivinilpirrolidona como intensificador de la solubilidad.
ES2178151T3 (es) Dilatador nasal medicinal de montaje externo.
NO20001003L (no) Transdermalt terapeutisk system omfattende et trykksensitivt adhesivt reservoarsjikt og et unidireksjonalt elastisk dekksjikt
ATE78704T1 (de) Transdermale monolithsysteme.
BRPI0411032A (pt) composição adesiva hidrófila, artigo médico, método para a fabricação da composição adesiva, e, dispositivo de administração transdérmica
AU622775B2 (en) A plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release, process for the production of the plaster and the use thereof
ES2045377T3 (es) Preparacion percutanea de tulobuterol.
DK0474647T3 (da) Fremgangsmåde og indretning til frigivelse af lægemidler til huden
BR9910063A (pt) Conjunto para fornecer um medicamento a um paciente, e, manufatura de uma embalagem
KR890001525A (ko) 지효성 경피 제제
ES2097845T3 (es) Material de gel acrilico y preparacion medica a base de gel para absorcion percutanea mediante el empleo del mismo.
BR0313092A (pt) Sistema de liberação transdérmica aperfeiçoado
BR0109893A (pt) Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 711551

Country of ref document: ES